A Study of RG-012 in Subjects With Alport Syndrome

Condition:   Alport Syndrome Intervention:   Drug: RG012 Sponsor:   Regulus Therapeutics Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alport Syndrome | Study